Cosgrove, S.E.; Carmeli, Y.
August 2003
Clinical Infectious Diseases;8/1/2003, Vol. 37 Issue 3, p459
Academic Journal
Responds to comments made about the authors' article on mortality rates among patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. Comparison with those among patients with methicillin-resistant S. aureus (MRSA) bacteremia; Lack of evidence suggesting that hospital-acquired MRSA infection is more lethal than hospital-acquired MSSA infection.


Related Articles

  • Mortality Rates Associated with Methicillin-Resistant and -Susceptible Staphylococcus aureus Infections. Whitby, M.; McLaw, M.-L.; Berry, G. // Clinical Infectious Diseases;8/1/2003, Vol. 37 Issue 3, p459 

    Presents a letter to the editor of the journal 'Clinical Infectious Diseases,' about how methicillin-resistant Staphylococcus aureus (MRSA) bacteremia carries a greater risk of mortality. Intrinsic differences in virulence between strains; Association of bacteremia with use of central...

  • Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia. Schwaber, Mitchell J.; Wright, Sharon B.; Carmeli, Yehuda; Venkataraman, Lata; DeGirolami, Paola C.; Gramatikova, Aneta; Perl, Trish M.; Sakoulas, George; gold, Howard S. // Emerging Infectious Diseases;Jun2003, Vol. 9 Issue 6, p657 

    We conducted a retrospective study of the clinical aspects of bacteremia caused by methicillin-resistant Staphylococcus aureus (MRSA) with heterogeneously reduced susceptibility to vancomycin. Bloodstream MRSA isolates were screened for reduced susceptibility by using brain-heart infusion agar,...

  • Daptomycin Resistance in Vancomycin-Intermediate Staphylococcus Aureus Isolate. Amchentsev, Alexey; Devakonda, Arun; Abraham, Teena; Saad, Nasser; Vastey, Fabienne; Colby, Steven; George, Liziamma // Internet Journal of Infectious Diseases;2009, Vol. 7 Issue 2, p6 

    We describe a patient with methicillin-resistant Staphylococcus aureus (MRSA) who developed resistance to daptomycin, a new cyclic lipopeptide recently approved for the treatment of infections by gram-positive organisms. Development of resistance to daptomycin during prolonged use may occur with...

  • PREVENTION A MAJOR FOCUS AT AUSTIN. Martin, Rhea // Australian Nursing Journal;Dec2008, Vol. 16 Issue 6, p36 

    The article offers information on a health program at Austin Health in Melbourne, Victoria, which uses Staphylococcus aureus bacteraemia (SAB) as a signal infection to prevent methicillin resistant Staphylococcus aureus (MRSA). The program, named Austin associated SAB (AuSAB), reviews every...

  • Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. Paul, Mical; Kariv, Galia; Goldberg, Elad; Raskin, Maria; Shaked, Hila; Hazzan, Rawi; Samra, Zmira; Paghis, Dina; Bishara, Jihad; Leibovici, Leonard // Journal of Antimicrobial Chemotherapy (JAC);Dec2010, Vol. 65 Issue 12, p2658 

    Objectives To document the effects of appropriate and inappropriate empirical antibiotic therapy on mortality in a cohort of patients with bacteraemia due to methicillin-resistant Staphylococcus aureus (MRSA) and to summarize effects with previous studies. Methods In the retrospective cohort...

  • Nonsocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: Mortality analyses and the impact of vancomycin, MIC = 2mg/L, by the broth microdilution method. Jiun-Ling Wang; Jann-Tay Wang; Wang-Huei Sheng; Yee-Chun Chen; Shan-Chwen Chang // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p159 

    Background: Previous studies regarding the prognosis of patients infected with MRSA isolates characterized by a high minimum inhibitory concentration (MIC) for vancomycin have generally used a commercial Etest. Little research has been conducted on determining the vancomycin susceptibility of...

  • Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus. Park, Ki-Ho; Kim, Eun Sil; Kim, Hee Seung; Park, Su-Jin; Bang, Kyung Mi; Park, Hyun Jung; Park, So-Youn; Moon, Song Mi; Chong, Yong Pil; Kim, Sung-Han; Lee, Sang-Oh; Choi, Sang-Ho; Jeong, Jin-Yong; Kim, Mi-Na; Woo, Jun Hee; Kim, Yang Soo // Journal of Antimicrobial Chemotherapy (JAC);Aug2012, Vol. 67 Issue 8, p1843 

    Objectives We compared the clinical characteristics and outcomes of, and the bacterial genotypes in, patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) and vancomycin-susceptible S. aureus (VSSA). Methods A total of 268 consecutive patients...

  • Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. Ellington, Matthew J.; Hope, Russell; Livermore, David M.; Kearns, Angela M.; Henderson, Katherine; Cookson, Barry D.; Pearson, Andrew; Johnson, Alan P. // Journal of Antimicrobial Chemotherapy (JAC);Mar2010, Vol. 65 Issue 3, p446 

    Objectives: Between 1998 and 2000, 95.6% of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemias in the UK were due to two epidemic strains, namely EMRSA-15 or EMRSA-16 (60.2% and 35.4%, respectively). We sought to determine the proportions of these strains before and after the...

  • Staying one jump ahead of resistant Staphylococcus aureus. Sanderson, P.J. // British Medical Journal (Clinical Research Edition);9/6/1986, Vol. 293 Issue 6547, p573 

    Details the control of methicillin-resistant Staphylococcus aureus. Publication of guidelines by the Hospital Infection Society and the British Society for Antimicrobial Chemotherapy; Display of transmissibility and virulence by the microbe; Difficulty in detecting the organism.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics